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The drugs are the essential tools and weapons in the human struggle with disease, 
but it is also a double-edged sword, may bring harmful reaction to patients in the 
treatment. Adverse drug reaction (ADR) is objective phenomenon and medical risks 
accompanied with the existence of drugs. While there are still much shortcomings of 
the ADR relief in China, which leading a considerable part of the victims suffer ADR 
at their own risks. By using comparative method and system analysis, this paper 
pointed out that the shortcomings of ADR relief in China through the comparison of 
the ADR relief mechanism of China and other countries, advises and countermeasures 
for perfecting ADR relief mechanisms were also suggested. 
The full text including introduction, main text and conclusions, of which the 
main text is divided into three chapters. 
Chapter I is Adverse Drug Reaction Relief Mechanism overview. The definition 
of ADR and ADR relief mechanism were introduced in this chapter, including the 
types of ADR, the adverse drug events, medical malpractice, the definition of ADR 
relief, and the characteristics of ADR relief, etc. And the related theories of ADR 
relief were also introduced, including the particular sacrifice theory, the danger 
liability theory, the market sharing liability theory, the fair burden equality theory, and 
the equality burden theory under the guidance of the principle of who benefits who 
bears, and so on. The ADR relief mechanism should consist of the ADR relief system, 
the implementation of the ADR relief system, the relationship of ADR relief and 
litigation etc. 
Chapter II is Status and Assessment of the ADR Relief Mechanism in China. The 
ADR relief mechanism in China were introduced and assessed through the analysis of 
legal and case in this chapter, pointed out that the shortcomings of the ADR relief 
mechanism in China, including the lack of specific operational legal, the lack of 
clearly defined of drug defects, the lack of statutory accreditation bodies and 
identification procedures, and the lack of special relief funding and so on. 
Chapter III is Thinking of the Improvement of ADR Relief Mechanism in China. 
The necessary of improvement of ADR relief mechanism was demonstrated through 















mechanism. The feasibility of establishment of the ADR relief mechanism was 
demonstrated through economic fundamentals, the technical support system, the risk 
spreading mechanisms and the social security mechanisms and so on. The issues need 
to be resolved in the perfection of the ADR relief mechanism were also demonstrated 
through the criteria of the drugs defects, the principle of ADR relief, the re-examine of 
the Tort Liability Law, the choose of relief mode, etc. And the countermeasures of 
improvement of the relief mechanism in China were suggested through improving the 
legislative system, setting up law enforcement agencies and so on.  
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病人发生药品不良反应的比率在 10%至 20%，其中 5%的患者会因为严重的药品
不良反应而死亡。在全世界死亡病人中，约有 1/3 的患者死于用药不当，药品不
良反应致死占社会人口死因的第四位。①据估计，我国不合理用药者占全体用药
者的 11%至 26%，在每年 5000 多万人次的住院病人中，有超过 500 万的患者在
住院期间发生过药品不良反应，药品不良反应每年导致 24 万患者死亡，是目前



















































































































第一章  药品不良反应损害救济机制概述 








第一节  药品不良反应与药品不良反应损害救济的界定 
一、药品不良反应的界定 
（一）药品不良反应的概念 
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